Magnesium and cardiovascular complications of chronic kidney disease
- 12 May 2015
- journal article
- review article
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 11 (7) , 432-442
Abstract
Cardiovascular complications are the leading cause of death in patients with chronic kidney disease (CKD). Abundant experimental evidence suggests a physiological role of magnesium in cardiovascular function, and clinical evidence suggests a role of the cation in cardiovascular disease in the general population. The role of magnesium in CKD-mineral and bone disorder, and in particular its impact on cardiovascular morbidity and mortality in patients with CKD, is however not well understood. Experimental studies have shown that magnesium inhibits vascular calcification, both by direct effects on the vessel wall and by indirect, systemic effects. Moreover, an increasing number of epidemiologic studies in patients with CKD have shown associations of serum magnesium levels with intermediate and hard outcomes, including vascular calcification, cardiovascular events and mortality. Intervention trials in these patients conducted to date have had small sample sizes and have been limited to the study of surrogate parameters, such as arterial stiffness, vascular calcification and atherosclerosis. Randomized controlled trials are clearly needed to determine the effects of magnesium supplementation on hard outcomes in patients with CKD.Keywords
This publication has 97 references indexed in Scilit:
- A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized studyNephrology Dialysis Transplantation, 2013
- Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremiaKidney International, 2013
- Magnesium and the Risk of Cardiovascular Events: A Meta-Analysis of Prospective Cohort StudiesPLOS ONE, 2013
- Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cellsNephrology Dialysis Transplantation, 2012
- Magnesium Intake and Risk of Type 2 DiabetesDiabetes Care, 2011
- Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent mannerNephrology Dialysis Transplantation, 2011
- Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerabilityNephrology Dialysis Transplantation, 2010
- Ultrastructural Analysis of Vascular Calcifications in UremiaJournal of the American Society of Nephrology, 2010
- Dietary magnesium, not calcium, prevents vascular calcification in a mouse model for pseudoxanthoma elasticumJournal of Molecular Medicine, 2010
- Elevated Dietary Magnesium Prevents Connective Tissue Mineralization in a Mouse Model of Pseudoxanthoma Elasticum (Abcc6−/−)Journal of Investigative Dermatology, 2009